CTOs on the Move

RotaChrom

www.rotachrom.com

 
RotaChrom Technologies is the inventor and first worldwide manufacturer of the Industrial Scale Centrifugal Partition Chromatography (iCPC) platforms. The company revolutionizes the pharmaceutical and cannabis industries by manufacturing and selling unique inventions of a special purifying technology. A cost-efficient and easily adaptable separation solution is offered for active pharmaceutical ingredients (API) and cannabinoids. The cost and the risk profile of R&D, as well as production can be significantly lower by using CPC tools, thereby pharmaceutical and cannabis-based products can become more widely available. Since its establishment, the company has achieved massive international success in pharmaceutical and pharma-graded cannabis purification. It has ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.rotachrom.com
  • 300 Spectrum Center Drive
    Irvine, CA USA 92618
  • Phone: 661.768.2247

Executives

Name Title Contact Details
Kelly Peterson
 Vice President of Technical Services Profile

Similar Companies

Institute for Therapy through the Arts

The Institute for Therapy through the Arts offers art therapy, music therapy, dance therapy, and drama therapy in Evanston, IL 60201 and Chicagoland.

Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reliance Health

Reliance Health is a non-profit community mental health center focused on enhancing health through mental wellness.

River Remedy

River Remedy is a medical cannabis company dedicated to serving Mississippi patients with the highest quality plant based medicine.

Telix Pharmaceuticals

Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States. Telix is developing a portfolio of clinical-stage products that address significant unmet medical needs in oncology and rare diseases.